Grace Life-tech Holdings Limited (HK:2112) has released an update.
Grace Life-tech Holdings Limited has announced a strategic cooperation with Tianjin Bingcao Gangmu Biotechnology Co., Ltd. to expand their health industry footprint using plant cambium stem cell technology. The partnership aims to capitalize on Bingcao Gangmu’s extensive sales network and smart health management system, with expectations to open over 1,000 health management centers and achieve over RMB 1 billion in sales by 2024. This collaboration is set to enhance Grace Life-tech’s market presence and foster growth in the plant stem cell industry.
For further insights into HK:2112 stock, check out TipRanks’ Stock Analysis page.
